Semiautomated platform delivers consistent batches of extracellular vesicles for potential regenerative therapies

A study led by researchers from the Germans Trias i Pujol Research Institute (IGTP) and the Blood and Tissue Bank (BST) has developed and validated a manufacturing platform for extracellular vesicles that meets pharmaceutical quality requirements, marking a key step toward their clinical application.

Read it at Phys.org ↗

← Front page